Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1937]
News [3134]
Articles [127]
Editorials [3]
Conferences [120]
elearning [13]
The changing landscape of the young investigator meeting at iwCLL 2015
Dr Giles Best and Prof Arnon Kater
The changing landscape of the young investigator meeting at iwCLL 2015 ( Dr Giles Best and Prof Arnon Kater )
8 Sep 2015
Ethnic variations in CLL prevalence
Dr Thomas Chan - Queen Mary Hospital, Hong Kong, China
Ethnic variations in CLL prevalence ( Dr Thomas Chan - Queen Mary Hospital, Hong Kong, China )
8 Sep 2015
Risk of bleeding-related adverse events in ibrutinib treated CLL patients
Dr Adrian Weistner - National Heart, Lung and Blood Institute, Maryland, USA
Risk of bleeding-related adverse events in ibrutinib treated CLL patients ( Dr Adrian Weistner - National Heart, Lung and Blood Institute, Maryland, USA )
8 Sep 2015
Epidemiology of CLL: Interlymph consortium and genome-wide sequencing studies
Prof Claire Vajdic - University of New South Wales, Sydney, Australia
Epidemiology of CLL: Interlymph consortium and genome-wide sequencing studies ( Prof Claire Vajdic - University of New South Wales, Sydney, Australia )
8 Sep 2015
Results of subgroup analysis of the HELIOS trial
Dr Paula Cramer – University of Cologne, Cologne, Germany
Results of subgroup analysis of the HELIOS trial ( Dr Paula Cramer – University of Cologne, Cologne, Germany )
8 Sep 2015
Primary results from the MABLE phase IIIb study
Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France
Primary results from the MABLE phase IIIb study ( Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France )
8 Sep 2015
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi...
Dr Amy Johnson – The Ohio State University, Columbus, USA
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors ( Dr Amy Johnson – The Ohio State University, Columbus, USA )
8 Sep 2015
Results of a new phase Ib trial of voxtalisib in combination with...
Prof Farrukh Awan - Ohio State University, Columbus, USA
Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy ( Prof Farrukh Awan - Ohio State University, Columbus, USA )
8 Sep 2015
A laboratory model of the hypoxic tumour microenvironment
Dr Giles Best - Royal North Shore Hospital, Sydney, Australia
A laboratory model of the hypoxic tumour microenvironment ( Dr Giles Best - Royal North Shore Hospital, Sydney, Australia )
8 Sep 2015
Will chemotherapy remain the cornerstone of CLL management?
Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany
Will chemotherapy remain the cornerstone of CLL management? ( Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany )
8 Sep 2015
Phase II study of idelalisib monotherapy in older CLL patients
Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA
Phase II study of idelalisib monotherapy in older CLL patients ( Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA )
7 Sep 2015
History of the B-cell in its 50th anniversary year
Prof Max Cooper - Emory University, Atlanta, USA
History of the B-cell in its 50th anniversary year ( Prof Max Cooper - Emory University, Atlanta, USA )
7 Sep 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation